Emma Watson Boosts Hertility's Funding to Over $14 Million in Female Health Revolution
Actress Emma Watson has made a previously undisclosed investment into the women’s health company Hertility, bringing its total funding to more than $14 million, the company revealed in an exclusive interview with TechCrunch. Watson's involvement highlights her support for women-led initiatives and her dedication to promoting gender equality, making her a natural fit as an investor in Hertility.
Founded by Dr. Helen O’Neill, Dr. Natalie Getreu, and Deidre O’Neill, Hertility aims to revolutionize women’s healthcare by providing personalized testing and services, including diagnostic testing, egg freezing, and telemedicine. The company is based in the U.K. where women are facing massive waiting times for healthcare services, prompting a need for more accessible and affordable options in the women’s health market.
A recent study by Deloitte found a significant gender gap in healthcare costs, with women spending 250% more than men on reproductive health. This highlights the importance of companies like Hertility in addressing the needs of women and empowering them to take control of their health and family planning.
Hertility's mission has attracted investments from notable investors, including Emma Watson, Local Globe, and the Sequoia Scout Fund. With plans for expansion and partnerships with leading brands, Hertility is on a mission to empower women globally and change behaviors surrounding hormone health and fertility.
In conclusion, Emma Watson's investment in Hertility signifies a growing trend in supporting women's health initiatives and addressing the gender gap in healthcare. By investing in companies like Hertility, individuals can contribute to empowering women and improving access to essential healthcare services. This not only benefits women's health but also has a positive impact on family planning and overall financial well-being.